Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03805100
What this trial is testing

Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD

Who this might be right for
Macular Degeneration
Xbrane Biopharma AB 582
Early research (Phase 1)Study completedNCT04894071
What this trial is testing

QA102 Phase 1 Study in Healthy Young and Older Adult Subjects

Who this might be right for
Age-related Macular Degeneration
Smilebiotek Zhuhai Limited 69
Testing effectiveness (Phase 2)Ended earlyNCT01624636
What this trial is testing

Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 1
Post-approval studies (Phase 4)Ended earlyNCT01319188
What this trial is testing

Ranibizumab and the Risk of Arterial Thromboembolic Events

Who this might be right for
Age-related Macular DegenerationCoronary Artery DiseaseCerebrovascular Disorders
Ural State Medical University 380
Not applicableEnded earlyNCT04468373
What this trial is testing

Study of WA-NG (NG-IMT) Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
VisionCare, Inc. 9
Post-approval studies (Phase 4)UnknownNCT03918590
What this trial is testing

Post Intravitreal Injection Topical NSAID vs. Patching

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
The New York Eye & Ear Infirmary 60
Post-approval studies (Phase 4)Study completedNCT02309281
What this trial is testing

Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab

Who this might be right for
Neovascular Age-related Macular Degeneration
Vista Klinik 33
Large-scale testing (Phase 3)UnknownNCT06229665
What this trial is testing

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)

Who this might be right for
Dry Age-related Macular Degeneration
LumiThera, Inc. 75
Post-approval studies (Phase 4)Study completedNCT00406107
What this trial is testing

Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Palmetto Retina Center, LLC 20
Not applicableLooking for participantsNCT06074731
What this trial is testing

Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography

Who this might be right for
Retinal DiseaseDiabetic RetinopathyMacular Degeneration
Johannes Kepler University of Linz 500
Not applicableEnded earlyNCT00709657
What this trial is testing

The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion

Who this might be right for
Macular DegenerationRegional Blood FlowVascular Endothelial Growth Factor
Medical University of Vienna 8
Not applicableLooking for participantsNCT07577219
What this trial is testing

Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss

Who this might be right for
Low VisionCentral Visual ImpairmentMacular Degeneration
New England College of Optometry 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT01736592
What this trial is testing

Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration

Who this might be right for
Stargardt's Disease
Sanofi 27
Post-approval studies (Phase 4)Study completedNCT03117634
What this trial is testing

An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy

Who this might be right for
Age Related Macular DegenerationPolypoidal Choroidal Vasculopathy
Singapore National Eye Centre 54
Large-scale testing (Phase 3)UnknownNCT00788177
What this trial is testing

Subretinal Macugen® for Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Klinikum Ludwigshafen 10
Very early researchNot Yet RecruitingNCT07728981
What this trial is testing

Biomarkers, Effectiveness, and Safety of Aflibercept 8mg Modified Fixed Dose Regimen in Treatment-Naïve nAMD Patients

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Tianjin Medical University Eye Hospital 49
Large-scale testing (Phase 3)Ended earlyNCT01402544
What this trial is testing

Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

Who this might be right for
Age-Related Macular Degeneration
University of California, San Diego 20
Testing effectiveness (Phase 2)UnknownNCT05380492
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationGeographic Atrophy
Perceive Biotherapeutics, Inc. 45
Testing effectiveness (Phase 2)Looking for participantsNCT06557460
What this trial is testing

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

Who this might be right for
Dry Age-related Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 24
Testing effectiveness (Phase 2)Study completedNCT00896779
What this trial is testing

Lucentis in Advanced Macular Degeneration

Who this might be right for
Macular Degeneration
Steven R. Sanislo 20
Next Page